|
Volumn 51, Issue 1306, 2009, Pages 13-14
|
PPI interactions with clopidogrel revisited
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
CYTOCHROME P450 2C19;
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
NIZATIDINE;
OMEPRAZOLE;
PANTOPRAZOLE;
PROTON PUMP INHIBITOR;
RANITIDINE;
ANTITHROMBOCYTIC AGENT;
CYP2C19 PROTEIN, HUMAN;
DRUG DERIVATIVE;
TICLOPIDINE;
UNSPECIFIC MONOOXYGENASE;
ACUTE HEART INFARCTION;
DRUG ACTIVATION;
DRUG ANTAGONISM;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GASTROINTESTINAL HEMORRHAGE;
GENETIC POLYMORPHISM;
HUMAN;
PRACTICE GUIDELINE;
RISK REDUCTION;
SHORT SURVEY;
ARTICLE;
CLINICAL TRIAL;
GENETICS;
METABOLISM;
ARYL HYDROCARBON HYDROXYLASES;
CLINICAL TRIALS AS TOPIC;
DRUG ANTAGONISM;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
POLYMORPHISM, GENETIC;
PROTON PUMP INHIBITORS;
TICLOPIDINE;
|
EID: 61849088896
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (9)
|
References (7)
|